Quick Takeaways
- Kynam Capital Management, LP filed SCHEDULE 13G/A for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN).
- Disclosed ownership: 1.5%.
- Date of event: 31 Dec 2025.
Kynam Capital Management, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN)
- Filing Manager
- Kynam Capital Management, LP
- Reporting Manager
- Kynam Capital Management, LP
- Symbol
- VRDN
- Shares outstanding
- 95,489,675 shares
- Disclosed Ownership
- 1,470,541 shares
- Ownership
- 1.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 12:52:53 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Kynam Capital Management, LP disclosed 1.5% ownership in Viridian Therapeutics, Inc. Common Stock, $0.01 par value (VRDN) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 17 Feb 2026, 12:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 1.5% | 1,470,541 | 0 | 1,470,541 | Yue Tang | Managing Member | |
| Kynam Capital Management GP, LLC | 1.5% | 1,470,541 | 0 | 1,470,541 | Yue Tang | Managing Member | |
| Yue Tang | 1.5% | 1,470,541 | 0 | 1,470,541 | Yue Tang | Self |